References
- Clark GM, Osborne CK and McGuire WL (1984) Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol 2, 1102-1109 https://doi.org/10.1200/JCO.1984.2.10.1102
- Shang Y, Hu X, DiRenzo J, Lazar MA and Brown M (2000) Cofactor dynamics and sufficiency in estrogen receptorregulated transcription. Cell 103, 843-852 https://doi.org/10.1016/S0092-8674(00)00188-4
- Osborne CK (1998) Tamoxifen in the treatment of breast cancer. N Engl J Med 339, 1609-1618 https://doi.org/10.1056/NEJM199811263392207
- Early Breast Cancer Trialists' Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365,1687-1717 https://doi.org/10.1016/S0140-6736(05)66544-0
- Garcia-Becerra R, Santos N, Diaz L and Camacho J (2012) Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance. Int J Mol Sci 14, 108-145 https://doi.org/10.3390/ijms14010108
- Musgrove EA and Sutherland RL (2009) Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 9, 631-643 https://doi.org/10.1038/nrc2713
- Wang KC, Helms JA and Chang HY (2009) Regeneration, repair and remembering identity: the three Rs of Hox gene expression. Trends Cell Biol 19, 268-275 https://doi.org/10.1016/j.tcb.2009.03.007
- Bhatlekar S, Fields JZ and Boman BM (2014) HOX genes and their role in the development of human cancers. J Mol Med (Berl) 92, 811-823 https://doi.org/10.1007/s00109-014-1181-y
- Shah N and Sukumar S (2010) The Hox genes and their roles in oncogenesis. Nat Rev Cancer 10, 361-371 https://doi.org/10.1038/nrc2826
- Svingen T and Tonissen KF (2003) Altered HOX gene expression in human skin and breast cancer cells. Cancer Biol Ther 2, 518-523 https://doi.org/10.4161/cbt.2.5.441
- Cantile M, Pettinato G, Procino A, Feliciello I, Cindolo L and Cillo C (2003) In vivo expression of the whole HOX gene network in human breast cancer. Eur J Cancer 39, 257-264 https://doi.org/10.1016/S0959-8049(02)00599-3
- Makiyama K, Hamada J, Takada M et al (2005) Aberrant expression of HOX genes in human invasive breast carcinoma. Oncol Rep 13, 673-679
- Morgan R, Boxall A, Harrington KJ et al (2012) Targeting the HOX/PBX dimer in breast cancer. Breast Cancer Res Treat 136, 389-398 https://doi.org/10.1007/s10549-012-2259-2
- Hur H, Lee JY, Yun HJ, Park BW and Kim MH (2014) Analysis of HOX gene expression patterns in human breast cancer. Mol Biotechnol 56, 64-71 https://doi.org/10.1007/s12033-013-9682-4
- Jin K and Sukumar S (2016) HOX genes: Major actors in resistance to selective endocrine response modifiers. Biochim Biophys Acta 1865, 105-110
- Lee JY, Hur H, Yun HJ et al (2015) HOXB5 promotes the proliferation and invasion of breast cancer cells. Int J Biol Sci 11, 701-711 https://doi.org/10.7150/ijbs.11431
- Jin K, Kong X, Shah T et al (2012) The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. Proc Natl Acad Sci U S A 109, 2736-2741 https://doi.org/10.1073/pnas.1018859108
- Jin K, Park S, Teo WW et al (2015) HOXB7 Is an ERalpha cofactor in the activation of HER2 and multiple ER target genes leading to endocrine resistance. Cancer Discov 5, 944-959 https://doi.org/10.1158/2159-8290.CD-15-0090
- Shah N, Jin K, Cruz LA et al (2013) HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERalpha and inducing IL-6 expression. Cancer Res 73, 5449-5458 https://doi.org/10.1158/0008-5472.CAN-13-1178
- Barber BA and Rastegar M (2010) Epigenetic control of Hox genes during neurogenesis, development, and disease. Ann Anat 192, 261-274 https://doi.org/10.1016/j.aanat.2010.07.009
- Srivastava S, Dhawan J and Mishra RK (2015) Epigenetic mechanisms and boundaries in the regulation of mammalian Hox clusters. Mech Deve 138 Pt 2, 160-169 https://doi.org/10.1016/j.mod.2015.07.015
- Daftary GS and Taylor HS (2006) Endocrine regulation of HOX genes. Endocr Rev 27, 331-355 https://doi.org/10.1210/er.2005-0018
- Cakmak H and Taylor HS (2010) Molecular mechanisms of treatment resistance in endometriosis: the role of progesterone-hox gene interactions. Semin Reprod Med 28, 69-74 https://doi.org/10.1055/s-0029-1242996
- Iorio MV, Casalini P, Piovan C, Braccioli L and Tagliabue E (2011) Breast cancer and microRNAs: therapeutic impact. Breast 20 Suppl 3, S63-70
- Xin F, Li M, Balch C et al (2009) Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance. Bioinformatics 25, 430-434 https://doi.org/10.1093/bioinformatics/btn646
- Hoppe R, Achinger-Kawecka J, Winter S et al (2013) Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptorpositive breast cancer following tamoxifen treatment. Eur J Cancer 49, 3598-3608 https://doi.org/10.1016/j.ejca.2013.07.145
- Jansen MP, Knijnenburg T, Reijm EA et al (2013) Hallmarks of aromatase inhibitor drug resistance revealed by epigenetic profiling in breast cancer. Cancer Res 73, 6632-6641 https://doi.org/10.1158/0008-5472.CAN-13-0704
- Nguyen VT, Barozzi I, Faronato M et al (2015) Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion. Nat Commun 6, 10044 https://doi.org/10.1038/ncomms10044
- di Pietro M, Lao-Sirieix P, Boyle S et al (2012) Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus. Proc Natl Acad Sci U S A 109, 9077-9082 https://doi.org/10.1073/pnas.1116933109
- Misteli T (2010) Higher-order genome organization in human disease. Cold Spring Harb Perspect Biol 2, a000794
- Deng C, Li Y, Zhou L et al (2016) HoxBlinc RNA recruits Set1/MLL complexes to activate Hox gene expression patterns and mesoderm lineage development. Cell Rep 14, 103-114 https://doi.org/10.1016/j.celrep.2015.12.007